021-51111890
购物车（）
sales@molnova.cn
GSK-1322322
CAS No. 1152107-25-9
GSK-1322322 ( Lanopepden;GSK-322 )
产品货号. M10536 CAS No. 1152107-25-9
A novel antibacterial agent that targets bacterial peptide deformylase; demonstrates in vitro activity against MDR respiratory and skin infection pathogens.
纯度: >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| 规格 | 价格/人民币 | 库存 | 数量 |
| 100MG | 获取报价 | 有现货 |
|
| 200MG | 获取报价 | 有现货 |
|
| 500MG | 获取报价 | 有现货 |
|
| 1G | 获取报价 | 有现货 |
|
生物学信息
-
产品名称GSK-1322322
-
注意事项本公司产品仅用于科研实验，不得用于人体或动物的临床与诊断
-
产品简述A novel antibacterial agent that targets bacterial peptide deformylase; demonstrates in vitro activity against MDR respiratory and skin infection pathogens.
-
产品描述A novel antibacterial agent that targets bacterial peptide deformylase; demonstrates in vitro activity against MDR respiratory and skin infection pathogens, including MDR Streptococcus pneumoniae and MRSA; inhibits S. pneumoniae ATCC 49619 with MIC of 0.12-0.5 ug/mL.
-
同义词Lanopepden;GSK-322
-
通路GPCR/G Protein
-
靶点Antibacterial
-
受体Antibacterial
-
研究领域Infection
-
适应症——
化学信息
-
CAS Number1152107-25-9
-
分子量479.56
-
分子式C22H34FN7O4
-
纯度>98% (HPLC)
-
溶解度——
-
SMILESCC1=NC(=C(C(=N1)N2CCN3CCOCC3C2)F)NNC(=O)C(CC4CCCC4)CN(C=O)O
-
化学全称N-((R)-2-(cyclopentylmethyl)-3-(2-(5-fluoro-6-((S)-hexahydropyrazino[2,1-c][1,4]oxazin-8(1H)-yl)-2-methylpyrimidin-4-yl)hydrazinyl)-3-oxopropyl)-N-hydroxyformamide
运输与储存
-
储存条件(-20℃)
-
运输条件With Ice Pack
-
稳定性≥ 2 years
参考文献
1. Ross JE, et al. J Clin Microbiol. 2011 Nov;49(11):3928-30.
2. Arat S, et al. Antimicrob Agents Chemother. 2015 Feb;59(2):1182-92.
3. O'Dwyer K, et al. Antimicrob Agents Chemother. 2013 May;57(5):2333-42.
2. Arat S, et al. Antimicrob Agents Chemother. 2015 Feb;59(2):1182-92.
3. O'Dwyer K, et al. Antimicrob Agents Chemother. 2013 May;57(5):2333-42.
产品手册
关联产品
-
2,6-Dichlorodiphenyl...
2,6-Dichlorodiphenylamine shows activity against Candida albicans infections. 2,6-Dichlorodiphenylamine elevated the MIC by 4-fold of diclofenac sodium (DFNa).
-
Negamycin
A dipeptide antibiotic that inhibits the initiation of protein synthesis; also restores dystrophin expression in skeletal and cardiac muscles of the mdx mouse.
-
VXc-486
VXc-486 (VXc486) is a novel inhibitor of gyrase B, potently inhibits multiple drug-sensitive isolates and drug-resistant isolates of Mycobacterium tuberculosis in vitro.
